Updates on Mediterranean diet and health status: active ingredients and pharmacological mechanisms
British Journal of Pharmacology · 2026-07 · 183 (13) · 3484-3502
DOI: 10.1111/bph.70441 ↗At a glance
Übersichtsarbeit in British Journal of Pharmacology, published online on 2026-04-19. Written by Lukas Schwingshackl and 3 co-authors. Institution: Institute for Evidence in Medicine, Faculty of Medicine and Medical Centre, University of Freiburg, Freiburg, Germany. Major MEDLINE topics: Diet, Mediterranean, Health Status. Cited 6 times so far (Crossref); 148 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
The Mediterranean diet (MedDiet) is among the most extensively studied dietary patterns and has been consistently associated with reduced risk of all‐cause mortality, cardiovascular disease, metabolic disorders, cognitive decline and several types of cancers. It is defined by a high intake of vegetables, fruits, legumes, nuts, (whole) grains, fish, seafood and extra virgin olive oil, along with moderate consumption of red wine. Several physiological pathways may contribute to its beneficial effects, including favourable modulation of lipid profiles, enhanced insulin sensitivity, reduction of inflammatory and oxidative stress markers, improved endothelial function and antithrombotic activity. These effects are largely attributed to bioactive compounds such as polyphenols, monounsaturated and polyunsaturated fatty acids and dietary fibre. This updated review summarizes the most recent evidence and discusses both established and emerging mechanisms of action related to individual dietary components within the MedDiet. It aims to provide a refined understanding of how this dietary pattern contributes to chronic disease prevention and overall health.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Institute for Evidence in Medicine, Faculty of Medicine and Medical Centre, University of Freiburg, Freiburg, Germany.
- SciLifeLab, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
- Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Nutritional Sciences, University of Vienna, Vienna, Austria.
ORCID profiles: Lukas Schwingshackl
Cite
APA
Schwingshackl, L., Morze, J., Wallerer, S., & Hoffmann, G. (2026). Updates on Mediterranean diet and health status: active ingredients and pharmacological mechanisms. British Journal of Pharmacology, 183(13), 3484-3502. https://doi.org/10.1111/bph.70441
Vancouver
Schwingshackl L, Morze J, Wallerer S, Hoffmann G. Updates on Mediterranean diet and health status: active ingredients and pharmacological mechanisms. British Journal of Pharmacology. 2026;183(13):3484-3502. doi:10.1111/bph.70441
BibTeX
@article{Schwingshackl2026,
author = {Schwingshackl, Lukas and Morze, Jakub and Wallerer, Sabina and Hoffmann, Georg},
title = {Updates on Mediterranean diet and health status: active ingredients and pharmacological mechanisms},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {13},
pages = {3484--3502},
doi = {10.1111/bph.70441}
}
EUVIMED